Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 68788-9138

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 68788-9138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

FDA Label Image

Orphenadrine Citrate Extended Release Tablets 100mg (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 02)

Orphenadrine Citrate Extended Release Tablets 100mg (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 02)
Orphenadrine Citrate Extended-Release Tablets 100mg is a generic medication used for the treatment of muscle spasms and pain. However, its transfer is prohibited by federal law. The tablets are white and round in shape. The manufacturer of the medicine is Lupin Pharmaceuticals, Inc. and the specific product number is S0 E3S808qg.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.